Related content

Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer

By Jiang Quan   Zheng Shilong   Wang Guangdi  

Future Medicinal Chemistry, Vol. 5, Iss. 9, 2013-06 ,pp. : 1023-1035

Future Science

Access to resources Recommend Favorite

Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor‐positive breast carcinoma cell line

By Kuang Wayne W.   Thompson Devon A.   Hoch Renee V.   Weigel Ronald J.  

Nucleic Acids Research, Vol. 26, Iss. 4, 1998-02 ,pp. : 1116-1123

Oxford University Press

Access to resources Recommend Favorite

Increased HER2/neu expression in recurrent hormone receptor-positive breast cancer

By Kaklamani Virginia G.   Cianfrocca Mary   Ciccone Jennifer   Kindy Kelly   Rademaker Alfred   Wiley Elizabeth L.   Gradishar William   O’Regan Ruth M.  

Biomarkers, Vol. 15, Iss. 2, 2010-03 ,pp. : 191-193

Informa Healthcare

Access to resources Recommend Favorite

Studies on the Relationship between Estrogen Receptor Content, Glutathione S-Transferase pi Expression, and Induction by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Drug Resistance in Human Breast Cancer Cells

By Hoivik D.   Wilson C.   Wang W.   Willett K.   Barhoumi R.   Burghardt R.   Safe S.  

Archives of Biochemistry and Biophysics, Vol. 348, Iss. 1, 1997-12 ,pp. : 174-182

Elsevier

Access to resources Recommend Favorite

Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells

By Tonetti D.A.   Rubenstein R.   DeLeon M.   Zhao H.   Pappas S.G.   Bentrem D.J.   Chen B.   Constantinou A.   Craig Jordan V.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 87, Iss. 1, 2003-10 ,pp. : 47-55

Elsevier

Access to resources Recommend Favorite